Our advanced AI technology allows you to increase probability of success for Phase 1 trials. Our software-based solution lets you identify key criteria for participants to achieve greater efficacy while maintaining safety.
Define specific criteria for study population
Determine optimal dose and dosing schedule
Predict prevalence of adverse events and understand correlations between them
Predicting Patient Outcomes with Graph Representation Learning Using LynxKite
Learn how to use graph representation learning to predict patient outcomes following admission to an Intensive Care Unit (ICU).